Target Healthcare REIT (LON:THRL) Hits New 1-Year High – Should You Buy?

Posted by Amy Steele on May 28th, 2026

Target Healthcare REIT (LON:THRL – Get Free Report) hit a new 52-week high during trading on Thursday . The stock traded as high as GBX 110.40 and last traded at GBX 108.40, with a volume of 610750 shares. The stock had previously closed at GBX 109.

Analyst Ratings Changes

Separately, Jefferies Financial Group reaffirmed a “hold” rating and set a GBX 101 price objective on shares of Target Healthcare REIT in a research note on Wednesday, May 6th. One equities research analyst has rated the stock with a Hold rating, According to MarketBeat, the company currently has an average rating of “Hold” and an average target price of GBX 101.

Read Our Latest Analysis on Target Healthcare REIT

Target Healthcare REIT Price Performance

The firm’s fifty day moving average is GBX 104.31 and its two-hundred day moving average is GBX 101.75. The firm has a market cap of £676.06 million, a P/E ratio of 8.67, a PEG ratio of 1.48 and a beta of 0.69.

Target Healthcare REIT (LON:THRL – Get Free Report) last issued its quarterly earnings data on Wednesday, March 18th. The company reported GBX 3.38 EPS for the quarter. Target Healthcare REIT had a net margin of 104.45% and a return on equity of 10.73%. As a group, sell-side analysts forecast that Target Healthcare REIT will post 6.2219101 EPS for the current year.

About Target Healthcare REIT

(Get Free Report)

Our investment objective is to provide shareholders with an attractive level of income together with the potential for capital and income growth, from a portfolio of UK care homes, diversified by tenant, geography, and resident payment profile. We only invest in modern, purpose-built homes.